Daniel Wachtlin

Safety and survival data in patients with idiopathic pulmonary fibrosis treated with nintedanib: pooled data from six clinical trials

Lisa Lancaster, Bruno Crestani, Paul Hernandez et al. · BMJ Open Respiratory Research · 2019 · 207 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Nerandomilast in Patients with Idiopathic Pulmonary Fibrosis

Luca Richeldi, Arata Azuma, Vincent Cottin et al. · New England Journal of Medicine · 2025 · 163 citations · Full text

Medicine, Clinical Sciences, Pharmacotherapy +13

Gemcitabine plus sorafenib versus gemcitabine alone in advanced biliary tract cancer: A double-blind placebo-controlled multicentre phase II AIO study with biomarker and serum programme

Markus Moehler, Annett Maderer, C Schimanski et al. · European Journal of Cancer · 2014 · 135 citations · Full text

Medicine, Oncology, Pharmacology +11

Neurofeedback of Slow Cortical Potentials in Children with Attention-Deficit/Hyperactivity Disorder: A Multicenter Randomized Trial Controlling for Unspecific Effects

Ute Strehl, Pascal-M. Aggensteiner, Daniel Wachtlin et al. · Frontiers in Human Neuroscience · 2017 · 122 citations · Full text

Medicine, Neuroscience, Pediatrics +12

An open-label, multicentre biomarker-oriented AIO phase II trial of sunitinib for patients with chemo-refractory advanced gastric cancer

Markus Moehler, Annett Mueller, J.T. Hartmann et al. · European Journal of Cancer · 2011 · 88 citations

Medicine, Oncology, Pharmacology +12